Sec Form 13D Filing - Trilogy Capital Group LLC filing for SMART FOR LIFE INC PAR $0. (SMFL) - 2022-03-21

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

 

SMART FOR LIFE, INC.

(Name of Issuer)

 

COMMON STOCK

(Title of Class of Securities)

 

83204U103

(CUSIP Number)

 

Alfonso J. Cervantes, Jr. c/o Trilogy Capital Group LLC 990 Biscayne Blvd., Suite 503 Miami, FL 33132 786-749-1221

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

March 10, 2022

(Date of Event which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No.

83204U103

 

1.	NAMES OF REPORTING PERSONS   Trilogy Capital Group LLC
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☐
3.	SEC USE ONLY
4.	SOURCE OF FUNDS   OO
5.	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6.	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware

NUMBER OF  SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:	7.	SOLE VOTING POWER
	8.	SHARED VOTING POWER	6,390,000
	9.	SOLE DISPOSITIVE POWER
	10.	SHARED DISPOSITIVE POWER	6,390,000

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   6,390,000
12.	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   20.50%(1)
14.	TYPE OF REPORTING PERSON   PN

 

(1)

Based on 31,169,710 shares of common stock of the Issuer outstanding as of March 21, 2022, as provided by the Issuer.

 

 

CUSIP No.

83204U103

 

1.	NAMES OF REPORTING PERSONS   Alfonso J. Cervantes, Jr.
2.	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a) ☐ (b) ☐
3.	SEC USE ONLY
4.	SOURCE OF FUNDS   OO
5.	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)	☐
6.	CITIZENSHIP OR PLACE OF ORGANIZATION   United States

NUMBER OF  SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:	7.	SOLE VOTING POWER	3,000,000(1)
	8.	SHARED VOTING POWER	6,390,000
	9.	SOLE DISPOSITIVE POWER	3,000,000(1)
	10.	SHARED DISPOSITIVE POWER	6,390,000

11.	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   9,390,000
12.	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES	☐
13.	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   29.19%(2)
14.	TYPE OF REPORTING PERSON   IN

 

(1)

Includes 1,000,000 shares of common stock that the Reporting Person has the right to acquire within sixty (60) days through the exercise of vested options.

 

(2)

Based on 31,169,710 shares of common stock of the Issuer outstanding as of March 21, 2022, as provided by the Issuer.

 

 

CUSIP No.

83204U103

 

Item 1. Security and Issuer.

 

This statement relates to the common stock of Smart for Life, Inc., a Delaware corporation (the “Issuer”), which has its principal executive offices at 990 Biscayne Blvd., Suite 503, Miami, FL 33132.

 

Item 2. Identity and Background.

 

(a)

This statement is being jointly filed by Trilogy Capital Group LLC, a Delaware limited liability company (“Trilogy”), and Alfonso J. Cervantes, Jr., an individual (together, the “Reporting Persons”).

 

(b)

The business address of the Reporting Persons is 990 Biscayne Blvd., Suite 503, Miami, FL 33132.

 

(c)

Trilogy is a private equity group principally engaged in the development of a series of private-to-public companies. Mr. Cervantes the Executive Chairman of Trilogy and the Executive Chairman of the Issuer.

 

(d)

During the last five years, neither Reporting Person has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

 

(e)

During the last five years, neither Reporting Person has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

(f)

Trilogy was organized in the State of Delaware. Mr. Cervantes is a citizen of the United States of America.

 

Item 3. Source and Amount of Funds or Other Consideration.

 

On February 7, 2017, Trilogy was issued 900,000 shares of common stock in exchange for services in connection with the organization of the Issuer.

 

On June 15, 2020, Trilogy was issued an additional 6,200,000 shares of common stock in exchange for services.

 

On April 8, 2021, Trilogy distributed 710,000 shares of common stock to a minority member of Trilogy.

 

As a result of these transactions, Trilogy directly holds 6,390,000 shares of common stock as of the date of this statement.

 

On June 15, 2020, Mr. Cervantes was issued 1,000,000 shares of common stock in exchange for services.

 

On September 14, 2020, Mr. Cervantes was issued an additional 750,000 shares of common stock and an option for the purchase of 1,000,000 shares of common stock in exchange for services. The option vested in full on the date of grant, has an exercise price of $0.01 per share, and expires on September 14, 2030.

 

On November 30, 2020, Mr. Cervantes was issued an additional 500,000 shares of common stock in exchange for services.

 

On December 25, 2020, Mr. Cervantes gifted 500,000 shares of common stock to a family member.

 

On March 10, 2020, Mr. Cervantes was granted a restricted stock award for 250,000 shares of common stock under the Issuer’s 2020 Stock Incentive Plan in exchange for services.

 

As a result of these transactions, Mr. Cervantes directly holds 2,000,000 shares of common stock and an option for the purchase of 1,000,000 shares of common stock as of the date of this statement.

 

 

CUSIP No.

83204U103

 

Item 4. Purpose of Transaction.

 

The securities held by the Reporting Persons were acquired in connection with the transactions described in Item 3 above.

 

The Reporting Persons have made no proposals, and have entered into no agreements, which would be related to or would result in any of the events o r matters described in part (a) through (j) of Item 4 of Schedule 13D.

 

Item 5. Interest in Securities of the Issuer.

 

(a)

As of the date of this statement, Trilogy is the beneficial owner of 6,390,000 shares of common stock, representing 20.50% of the outstanding common stock of the Issuer, and Mr. Cervantes is the beneficial owner of 9,390,000 shares of common stock, representing 29.19% of the outstanding common stock of the Issuer, which includes (i) 2,000,000 shares of common stock held by Mr. Cervantes directly, (ii) an option to purchase 1,000,000 shares of common stock held by Mr. Cervantes directly and (iii) 6,390,000 shares of common stock held by Trilogy. Mr. Cervantes is the Executive Chairman of Trilogy and has voting and investment power over the securities held by it. As a result, Mr. Cervantes may be deemed to be the beneficial owner of the shares held by Trilogy. Mr. Cervantes disclaims beneficial ownership of the shares held by Trilogy except to the extent of his pecuniary interest, if any, in such shares. The Reporting Persons do not own any other securities of the Issuer.

 

(b)

Trilogy and Mr. Cervantes have shared power to vote and dispose of 6,390,000 shares of common stock. Mr. Cervantes has the sole power to vote and dispose of 3,000,000 shares of common stock.

 

(c)

Other than the transactions discussed in Item 3 hereof, the contents of which are incorporated herein by reference, the Reporting Persons did not effect any transactions in the Issuer’s securities within the past 60 days.

 

(d)

Other than the Reporting Persons, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Reporting Persons’ securities.

 

(e)

Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

 

None.

 

Item 7. Material to be Filed as Exhibits.

 

Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each of the Reporting Persons.

 

 

CUSIP No.

83204U103

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: March 21, 2022	Trilogy Capital Group LLC
	By:	/s/ Alfonso J. Cervantes, Jr.
	Name:	Alfonso J. Cervantes, Jr.
	Title:	Executive Chairman
	/s/ Alfonso J. Cervantes, Jr.
	Alfonso J. Cervantes, Jr.

 

 

6